DATE: 19th of June 2018

Organiser: Dr. Katerina Sideri (TECHNIS)

Venue: Tsuzuki Lecture Theatre, St Anne’s College, Oxford.

Resource Allocation in Personalised Medicine:

Evaluation, Translation & Ethics

19th of June 2018

Tsuzuki Lecture Theatre, St Anne’s College, Oxford

Co-Organiser: Dr. Katerina Sideri (TECHNIS)

Welcome to the third in the series Personalised Medicine, Ethics and the Market, a collaboration between the Centre for Personalised Medicine and the Ethox Centre, University of Oxford. This year we welcome the Health Economics Research Centre as co-collaborators.

It is evident that healthcare services need to utilise advances in genomic technology and knowledge for the benefit of patients. The availability of new genetic tests as well as their use in healthcare is expanding rapidly and is being expedited by the 100,000 Genomes Project in the UK, however national coverage decisions for the integration of genomic medicine into the National Healthcare Service have been slow, complex and fraught with controversy. 

The future delivery of genomic and personalised medicine within the NHS is integrally related to the health system process of priority setting and resource allocation within commissioning arrangements. The fair, equitable and appropriate commissioning of genomic medicine services requires rigorous exploration of the ethical, policy and practical implications. 

Achieving appropriate integration of genomic medicine into healthcare will require full and proper consideration of multiple ethical and economic factors such as cost, opportunity cost, clinical effectiveness, cost-effectiveness, need, ability to benefit and procedural fairness. The challenge in priority setting and resource allocation is to find a way forward giving these conflicting considerations appropriate weight in each case. 

We invite you to join us at this conference, which will consider three broad themes: 

·      The Clinical Context: How should we understand current and future developments in clinical commissioning structures, organisation and delivery?

·      The Health Economic Context: What are the current developments and trends in assessing economic evidence relating to personalised medicine?

·      The International Ethics and Policy Context: What is the international ‘direction of travel’ in thinking about resource allocation related to genomic medicine?


Intellectual Property, Ethics and the Market in the Era of Personalised Medicine at St. Anne’s college University of Oxford on the 12th of June 2017

Organiser: Dr. Katerina Sideri (TECHNIS)

Venue: St Anne's College, Oxford

Markets, ethics and big data conference at St. Anne’s college University of Oxford on 20th June 2016

Organiser: Dr. Katerina Sideri (TECHNIS)

Venue: St Anne's College, Oxford


Technology transfer as a driver of innovative entrepreneurship in agriculture and the agri-food industry, 15-16 July 2015

Organiser: Dr. Kyriakos Drivas (TECHNIS)

Venue: Mediterranean Agronomic Institute of Chania, Crete, Greece


Patent Policy in Genomics and Human Genetics: A Public Health Perspective,  Wednesday 11 February 2015

Organiser: Dr Katerina Sideri (TECHNIS)

Venue: Haldane Room, Wolfson College, Linton Road, Oxford


Intellectual ‘Property’: From History to Policy and Entrepreneurial Concerns, 11-12 February 2014

Organiser: Dr Stathis Arapostathis (TECHNIS)

Venue: National Hellenic Research Foundation, Athens, Greece

An Intellectual Property and Innovation Research Group